Abstract
Background: Computed Tomography is a significant imaging modality in cancer staging, the extent of disease evaluation, and cure management for breast cancer women. The purpose of the current study was to determine the prognostic value of metastasis in breast cancer patients on computed tomography. Objective: The present study explores the frequency of breast cancer Metastasis and the extent on computed tomography in Gujranwala, Pakistan. Material and Method: A cross-sectional study was organized at the diagnostic department of radiology (DHQ/Teaching Hospital, Gujranwala). The duration of the study was 3 months i.e. 23rd January 2022 to 23rd April 2022. The total number of participants was 50 with primary breast cancer. Between 23rd January 2022 and 23rd April 2022, 50 breast cancer patients who underwent computed tomography for verification of breast cancer metastasis were analyzed. Volume acquisition in axial sections with multi-slice CT of the abdomen from chest to the pubic symphysis was done for the assessment. Results: At the time of diagnosis, 29 patients (58%) did not have while 21 patients (42%) had metastasis. Information on histological types was available for 50 primary breast cancer patients. These were (22%) Ductal carcinoma, (4%) inflammatory, and (74%) other subtypes. On patient-based analysis, computed tomography identified distant metastasis in axillary lymph nodes (44%), pulmonary (8%), hepatic (2%), and bone (4%) and 3 patients (6%) had metastasis extended to ALN, pulmonary, hepatic and bone. Conclusion: Breast CT with contrast upgrade lesion visualization could be advantageous for the determining extent of metastasis The breast CT radiation dose is complementary to and is within the dimension of conventional mammography imaging. Given all the possible aspects, imaging of breast techniques in addition to biopsies guidance, adjunctive screening, and evaluation of diagnosis, the extent of disease evaluation, and examining feedback to ..............
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
